Home
BDTX
BDTX News

Latest Black Diamond Therapeutics Inc. (BDTX) News on September 15, 2025

Is BDTX's Cash balance Enough to Successfully Develop Its NSCLC Drug?

Zacks

3 days ago

Is BDTX's Cash balance Enough to Successfully Develop Its NSCLC Drug?

Black Diamond Therapeutics, Inc. (BDTX) Rated Outperform as Lead Drug Shows Promise

Insider Monkey

2 months ago

Black Diamond Therapeutics, Inc. (BDTX) Rated Outperform as Lead Drug Shows Promise

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference

GlobeNewswire

4 months ago

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference

Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

4 months ago

Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Positive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past year

Simply Wall St.

4 months ago

Positive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past year

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

6 months ago

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

Servier and Black Diamond sign deal for solid tumours therapy

Pharmaceutical Technology

6 months ago

Servier and Black Diamond sign deal for solid tumours therapy

MT Newswires

6 months ago

Sector Update: Health Care

MT Newswires

6 months ago

Top Midday Gainers

MT Newswires

6 months ago

Black Diamond Therapeutics, Servier Sign Global Licensing Deal for BDTX-4933 to Treat Solid Tumors

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy

GlobeNewswire

6 months ago

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy

MT Newswires

6 months ago

Wedbush Adjusts Black Diamond Therapeutics Price Target to $11 From $16, Maintains Outperform Rating

Associated Press Finance

6 months ago

Black Diamond: Q4 Earnings Snapshot

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

NAYA Biosciences Announces Nomination of New Board Members

GlobeNewswire

7 months ago

NAYA Biosciences Announces Nomination of New Board Members

February 2025 US Penny Stocks With Promising Prospects

Simply Wall St.

7 months ago

February 2025 US Penny Stocks With Promising Prospects

3 US Penny Stocks With Market Caps Under $200M

Simply Wall St.

8 months ago

3 US Penny Stocks With Market Caps Under $200M

Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks

TipRanks

8 months ago

Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks

US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks

Simply Wall St.

9 months ago

US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks

Associated Press Finance

10 months ago

Black Diamond: Q3 Earnings Snapshot

Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks

Simply Wall St.

10 months ago

Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks

Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

10 months ago

Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

10 months ago

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

MT Newswires

a year ago

Black Diamond Cuts Programs, Workforce to Save Funding for Prospective Lung Cancer Therapy

Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway

GlobeNewswire

a year ago

Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug

Benzinga

a year ago

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise Pre-Bell Monday

MT Newswires

a year ago

Sector Update: Health Care

MT Newswires

a year ago

Black Diamond Therapeutics Reports 'Robust Anti-Tumor Activity' in Phase 2 BDTX-1535 Trial for Cell Lung Cancer

MT Newswires

a year ago

Top Premarket Gainers

Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations

GlobeNewswire

a year ago

Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations

Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC

GlobeNewswire

a year ago

Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC

Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024

GlobeNewswire

a year ago

Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors

GlobeNewswire

a year ago

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors

All You Need to Know About Black Diamond (BDTX) Rating Upgrade to Buy

Zacks

a year ago

All You Need to Know About Black Diamond (BDTX) Rating Upgrade to Buy

Associated Press Finance

a year ago

Black Diamond: Q2 Earnings Snapshot

Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

MT Newswires

a year ago

Raymond James Initiates Black Diamond Therapeutics at Outperform

Will Black Diamond Therapeutics (NASDAQ:BDTX) Spend Its Cash Wisely?

Simply Wall St.

a year ago

Will Black Diamond Therapeutics (NASDAQ:BDTX) Spend Its Cash Wisely?

Is Black Diamond Therapeutics, Inc. (BDTX) a Good Biotech Penny Stock to Buy Right Now?

Insider Monkey

a year ago

Is Black Diamond Therapeutics, Inc. (BDTX) a Good Biotech Penny Stock to Buy Right Now?

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

a year ago

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is favoured by institutional owners who hold 60% of the company

Simply Wall St.

a year ago

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is favoured by institutional owners who hold 60% of the company

MT Newswires

a year ago

HC Wainwright Adjusts Price Target on Black Diamond Therapeutics to $11 From $12, Keeps Buy Rating

Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?

Zacks

a year ago

Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?

Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Associated Press Finance

a year ago

Black Diamond: Q1 Earnings Snapshot

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

a year ago

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

a year ago

Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock?

Black Diamond Therapeutics Announces Changes to Board of Directors

GlobeNewswire

a year ago

Black Diamond Therapeutics Announces Changes to Board of Directors

Wall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know

Zacks

a year ago

Wall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting

GlobeNewswire

a year ago

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

How Much Upside is Left in Black Diamond Therapeutics (BDTX)? Wall Street Analysts Think 95.93%

Zacks

a year ago

How Much Upside is Left in Black Diamond Therapeutics (BDTX)? Wall Street Analysts Think 95.93%

GuruFocus.com

2 years ago

Black Diamond Therapeutics Inc (BDTX) Reports Q4 and Full Year 2023 Financials, Advances ...

Associated Press Finance

2 years ago

Black Diamond: Q4 Earnings Snapshot

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

2 years ago

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024

GlobeNewswire

2 years ago

Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024

Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

GlobeNewswire

2 years ago

Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

FANHUA Announces Significant Investment from White Group

GlobeNewswire

2 years ago

FANHUA Announces Significant Investment from White Group

LifeMD (NASDAQ:LFMD) shareholders have earned a 49% CAGR over the last five years

Simply Wall St.

2 years ago

LifeMD (NASDAQ:LFMD) shareholders have earned a 49% CAGR over the last five years

18 Best 52-Week Low Stocks To Buy Now

Insider Monkey

2 years ago

18 Best 52-Week Low Stocks To Buy Now

GlobeNewswire

2 years ago

RGC Resources, Inc. Schedules First Quarter 2024 Earnings Call

BlackRock Capital Investment Corporation to Report Fourth Quarter 2023 Earnings on March 5, 2024

Business Wire

2 years ago

BlackRock Capital Investment Corporation to Report Fourth Quarter 2023 Earnings on March 5, 2024

USCB Financial Holdings Inc Reports Mixed Results Amid Economic Headwinds

GuruFocus.com

2 years ago

USCB Financial Holdings Inc Reports Mixed Results Amid Economic Headwinds

Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod

Benzinga

2 years ago

Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod

Aragon Research positions LivePerson as a Leader in The Aragon Research Globe™ Report for Conversational AI, 2024

PR Newswire

2 years ago

Aragon Research positions LivePerson as a Leader in The Aragon Research Globe™ Report for Conversational AI, 2024

LivePerson (LPSN) Opts for Net Operating Loss Rights Plan

Zacks

2 years ago

LivePerson (LPSN) Opts for Net Operating Loss Rights Plan

SpartanNash Implements New Food Traceability Program, Strengthening Safety and Transparency Throughout Its Global Supply Chain

PR Newswire

2 years ago

SpartanNash Implements New Food Traceability Program, Strengthening Safety and Transparency Throughout Its Global Supply Chain

Software Development Stocks Q3 Earnings: Datadog (NASDAQ:DDOG) Best of the Bunch

StockStory

2 years ago

Software Development Stocks Q3 Earnings: Datadog (NASDAQ:DDOG) Best of the Bunch

Expanding ReposiTrak Traceability Network Welcomes Nut Butter Supplier and Three New Produce Suppliers

Business Wire

2 years ago

Expanding ReposiTrak Traceability Network Welcomes Nut Butter Supplier and Three New Produce Suppliers

Sify Technologies Limited (NASDAQ:SIFY) Q3 2024 Earnings Call Transcript

Insider Monkey

2 years ago

Sify Technologies Limited (NASDAQ:SIFY) Q3 2024 Earnings Call Transcript

Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth?

Simply Wall St.

2 years ago

Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth?

Invesco Municipal Trust's Dividend Analysis

GuruFocus.com

2 years ago

Invesco Municipal Trust's Dividend Analysis

AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific

GlobeNewswire

2 years ago

AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific

AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update

GlobeNewswire

2 years ago

AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update

Baillie Gifford Trims Position in Codexis Inc

GuruFocus.com

2 years ago

Baillie Gifford Trims Position in Codexis Inc

Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),

Simply Wall St.

2 years ago

Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

GlobeNewswire

2 years ago

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

Wall Street Analysts See a 197.7% Upside in C4 Therapeutics, Inc. (CCCC): Can the Stock Really Move This High?

Zacks

2 years ago

Wall Street Analysts See a 197.7% Upside in C4 Therapeutics, Inc. (CCCC): Can the Stock Really Move This High?

LianBio Announces Departure of Chief Financial Officer

GlobeNewswire

2 years ago

LianBio Announces Departure of Chief Financial Officer

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

Zacks

2 years ago

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences

GlobeNewswire

2 years ago

Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

GlobeNewswire

2 years ago

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation

PR Newswire

2 years ago

Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation

Whitestone REIT Board of Trustees Responds to Proposal from Bruce Schanzer / Erez Asset Management, LLC (“Erez”)

GlobeNewswire

2 years ago

Whitestone REIT Board of Trustees Responds to Proposal from Bruce Schanzer / Erez Asset Management, LLC (“Erez”)

Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM

GlobeNewswire

2 years ago

Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM

New Strong Buy Stocks for December 8th

Zacks

2 years ago

New Strong Buy Stocks for December 8th

3 Stocks at the Forefront of Personalized Medicine Trend

InvestorPlace

2 years ago

3 Stocks at the Forefront of Personalized Medicine Trend

With 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional backing

Simply Wall St.

2 years ago

With 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional backing

Investing in Hallador Energy (NASDAQ:HNRG) three years ago would have delivered you a 964% gain

Simply Wall St.

2 years ago

Investing in Hallador Energy (NASDAQ:HNRG) three years ago would have delivered you a 964% gain

Duluth Holdings Inc. (NASDAQ:DLTH) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Duluth Holdings Inc. (NASDAQ:DLTH) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Duluth Holdings Inc Earnings Call

Duluth (DLTH) Q3 2023 Earnings Call Transcript

Motley Fool

2 years ago

Duluth (DLTH) Q3 2023 Earnings Call Transcript

Business Wire

2 years ago

Everest Consolidator Acquisition Corporation Receives NYSE Notice Regarding Delayed Form 10-Q Filing

Richtech Robotics Announces Closing of Upsized Initial Public Offering

GlobeNewswire

2 years ago

Richtech Robotics Announces Closing of Upsized Initial Public Offering

Why BeautyHealth (SKIN) Shares Are Sliding Today

StockStory

2 years ago

Why BeautyHealth (SKIN) Shares Are Sliding Today

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

Business Wire

2 years ago

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

GuruFocus.com

2 years ago

The Beauty Health Co (SKIN) Faces Headwinds: Q3 Earnings Reveal Challenges and Revised Guidance

BeautyHealth Reports Third Quarter 2023 Financial Results

Business Wire

2 years ago

BeautyHealth Reports Third Quarter 2023 Financial Results

Share on Social Networks: